Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances

Conditions: Mesopic Vision; Night Vision Loss Interventions: Drug: phentolamine ophthalmic solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist; Drug: Placebo Sponsors: Ocuphire Pharma, Inc.; Viatris Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials